CD4+ T Cell Recovery and Hepatitis B Virus Coinfection in HIV-Infected Patients from Côte d'Ivoire Initiating Antiretroviral Therapy

AIDS Research and Human Retroviruses
Laura HoughtalingAnders Boyd

Abstract

Immunorecovery could be attenuated in HIV-hepatitis B virus (HBV) coinfection versus HIV monoinfection during antiretroviral therapy (ART), yet, whether it also occurs in individuals from sub-Saharan Africa without severe comorbidities is unknown. In this study, 808 HIV-infected patients in Côte d'Ivoire initiating continuous ART were included. Six-month CD4+ count trajectories and the proportion reaching CD4+ T cell counts >350/mm3, HIV-RNA <300 copies/mL, still alive and not lost to follow-up within 18 months ("optimal immunorecovery") were compared between coinfected groups. At inclusion, 80 (9.9%) patients were HIV-HBV coinfected, 40 (50.0%) of whom had high HBV-DNA viral load (VL) (>104 copies/mL). Coinfected patients with high HBV-DNA replication initiated ART with significantly lower median CD4+ T cell counts [216/mm3, interquartile range (IQR) = 150-286] compared to coinfection with low HBV-DNA replication (268/mm3, IQR = 178-375) or HIV monoinfection (257/mm3, IQR = 194-329) (p = .003). These patients had significantly faster rates of CD4+ cell count increase from baseline after adjusting for baseline age, World Health Organization stage III/IV, and CD4+ cell counts (p = .04), yet, were not more likely to exhibit optim...Continue Reading

References

Jul 16, 2003·HIV Medicine·D LincolnUNKNOWN Australian HIV Observational Database
Jul 12, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gilbert R KaufmannUNKNOWN Swiss HIV Cohort Study
Apr 25, 2006·The Lancet Infectious Diseases·Manuel BattegayGilbert R Kaufmann
Oct 22, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christopher J HoffmannChloe L Thio
Apr 1, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anna Maria GerettiUNKNOWN UK Collaborative Group on HIV Drug Resistance
Sep 24, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John IdokoChloe L Thio
Apr 26, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·George N IoannouEdward J Boyko
Aug 1, 2013·The Journal of Infectious Diseases·Gilles WandelerUNKNOWN Swiss HIV Cohort Study
Mar 7, 2014·Journal of the International AIDS Society·Simbarashe TakuvaMatthew P Fox
Apr 4, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Helen M ChunUNKNOWN Infectious Disease Clinical Research Program HIV Working Group
Jul 1, 2014·The Journal of Infection·Fred Stephen SarfoDavid R Chadwick
Nov 17, 2017·The American Journal of Tropical Medicine and Hygiene·Anders Boyd For The Anrs Trivacan And Anrs VarBVA Studies

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Clinical Trials Mentioned

NCT00158405

Software Mentioned

STATA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.